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Background: Home-based noninvasive ventilation has proven cost-effective. But, adherence to therapy still constitutes a
common clinical problem. We hypothesized that a behavioral intervention supported by a mobile health (mHealth) app could
enhance patient self-efficacy. It is widely accepted that mHealth-supported services can enhance productive interactions among
the stakeholders involved in home-based respiratory therapies.
Objective: This study aimed to measure changes in self-efficacy in patients with chronic respiratory failure due to diverse
etiologies during a 3-month follow-up period after the intervention. Ancillary objectives were assessment of usability and
acceptability of the mobile app as well as its potential contribution to collaborative work among stakeholders.
Methods: A single-blind, single-center, randomized controlled trial was conducted between February 2019 and June 2019 with
67 adult patients with chronic respiratory failure undergoing home-based noninvasive ventilation. In the intervention group, a
psychologist delivered a face-to-face motivational intervention. Follow-up was supported by a mobile app that allowed patients
to report the number of hours of daily noninvasive ventilation use and problems with the therapy. Advice was automatically
delivered by the mobile app in case of a reported problem. The control group received usual care. The primary outcome was the
change in the Self Efficacy in Sleep Apnea questionnaire score. Secondary outcomes included app usability, app acceptability,
continuity of care, person-centered care, and ventilatory parameters.
Results: Self-efficacy was not significantly different in the intervention group after the intervention (before: mean 3.4, SD 0.6;
after: mean 3.4, SD 0.5, P=.51). No changes were observed in adherence to therapy nor quality of life. Overall, the mHealth tool
had a good usability score (mean 78 points) and high acceptance rate (mean score of 7.5/10 on a Likert scale). It was considered
user-friendly (mean score of 8.2/10 on a Likert scale) and easy to use without assistance (mean score of 8.5/10 on a Likert scale).
Patients also scored the perception of continuity of care and person-centered care as high.
Conclusions: The integrated care intervention supported by the mobile app did not improve patient self-management. However,
the high acceptance of the mobile app might indicate potential for enhanced communication among stakeholders. The study
identified key elements required for mHealth tools to provide effective support to collaborative work and personalized care.
Trial Registration: ClinicalTrials.gov NCT03932175; https://clinicaltrials.gov/ct2/show/NCT03932175
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Introduction
In the 1950s, the polio epidemic demonstrated the safety and
efficacy of noninvasive ventilation (NIV) to decrease mortality
[1]. Since then, the use of this therapeutic approach at home has
reduced hospital admissions, has favorably impacted
health-related quality of life, improved sleep quality, and
reduced mortality in patients with chronic respiratory failure
due to diverse etiologies [2-8]. These results have driven a
steady increase in the prevalence of patients using home-based
NIV in Europe, ranging from 4.5 to 20 per 100,000 adults [9-11].
Despite its proven cost-effectiveness [12], patient adherence to
home-based NIV could still improve, which should further
enhance health care–related efficiencies of the intervention [13].
Monitoring and optimization of physiological settings have
enhanced adherence by improving the timely detection of
problems such as mask leaks and patient-ventilator asynchronies
[14]. Nevertheless, improvement in the behavioral aspects such
as patient motivation and empowerment for self-management
are important factors to consider when addressing adherence to
respiratory therapies.
The current study sought to explore the transfer of previous
positive experiences with behavioral interventions in other fields
(ie, physical activity) [15-20] to home-based NIV. Specifically,
we addressed the concept of self-efficacy, defined as the
individual’s perceived capability to perform a particular behavior
[21]. Self-efficacy expectations can be affected by enablers or
barriers such as the perception of physical function or the
capacity for self-management. Therefore, a person who does
not believe in her or his capacity to perform the desired action
will fail to adopt, initiate, and maintain it. Self-efficacy is
therefore seen as the most influential motivational factor and
the strongest predictor of behavioral intentions [21].
We propose the use of a behavioral mobile health (mHealth)
intervention, which can be framed by Bandura’s model [22], to
support changes in self-efficacy. This model is based on the
concepts of health risk perceptions, health outcome expectancies,
and the patients’confidence to engage in certain behaviors. The
model has been widely applied in studies of the adoption,
initiation, and maintenance of health-promoting behaviors [23].
In addition to self-efficacy as a way to influence behavioral
change, previous reports by Hernandez et al [24] and Cano et
al [25] identified two common hinderances for the effective
implementation of complex respiratory therapies (ie, long-term
oxygen therapy, continuous positive airway pressure therapy,
home NIV, and home-based nebulizer therapy). First, interaction
and communication, which could greatly benefit from digital
tools supporting collaborative work, are needed among several
stakeholders, namely health professionals at different health
care tiers (eg, primary care, specialized care), patients and carers,
companies undertaking equipment maintenance, and others.
Second, improvement in therapeutic adherence is needed, which
could be achieved by empowering patients to perform
self-management.
Within this context, information and communication
technologies (ICT) have been identified as promising tools to
enhance the coordination between stakeholders and contribute
to improved health outcomes [26,27]. Nonetheless, the
implementation remains immature [28] due to a lack of evidence
in a real-world context for the capacity of ICT to sustain
behavioral changes, including self-efficacy, in patients with
chronic, complex conditions. It is widely accepted that, despite
current limitations, patients with chronic, complex conditions
are an ideal population for which care coordination, patient and
medical staff satisfaction, and patient empowerment are of the
utmost importance to produce health benefits.
The principal objective of this study was to explore the capacity
of a behavioral mHealth intervention to increase patient
empowerment for self-management and adherence to therapy.
The secondary aim was to learn, based on the experience of
professionals and patients, how the mHealth tool should evolve
to support collaborative work.
Methods
Study Design and Participants
A single-blind, single-center, randomized controlled trial with
two parallel arms (1:1 ratio) was conducted. Patients were
randomized to a control group or an intervention arm, which
consisted of the behavioral mHealth intervention in addition to
usual care. Inclusion criteria were as follows: all adult patients
with hypercapnic ventilatory failure due to chest wall,
neuromuscular, lung parenchyma, or airway disease already
receiving treatment with NIV irrespective of treatment duration
and in possession of a mobile phone or tablet that could support
the use of the mHealth app (MyPathway). MyPathway [29] is
a secure, digital communication channel connecting patients to
clinicians and services. It is an app-based tool for both patients
and clinicians to use on phones or tablets. See Multimedia
Appendix 1 for more details. Patients with severe psychiatric
or neurological diseases were excluded, as well as patients
hospitalized at the time of assessment.
Intervention
In addition to usual care, the behavioral mHealth intervention
included a face-to-face motivational interview by a psychologist
(EA) to assess the patient’s adherence profile and lifestyle
habits, with a follow-up through the MyPathway app. In
contrast, the control group received only usual care, which
consisted of manual discharge and review of the NIV machine
data by the treating pulmonologist and respiratory nurse.
Respiratory parameters were changed, if needed, according to
clinical data (anamnesis and physical examination) in addition
to NIV data.
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At the time of enrollment, semi-structured motivational
interviews were conducted individually. Participants were asked
about their treatment adaptation experience, lifestyle (physical
activity and food habits), and use of ICT. In each session, field
notes were taken anonymously, and no recordings were made.
The intervention consisted of a 10-50–minute face-to-face
session at the hospital or participants' home that followed the
principles of a collaborative and evocative motivational
interview, favoring the participant's autonomy. The techniques
used were open questions, active listening, empathy, returning
reflected thoughts, exploring a change in goals, summarizing,
and giving feedback. Also, during the enrollment visit, patients
were given verbal and written explanation on how to use the
app. Free access was granted after receiving an invitation via
the hospital health information system (SAP), which prompted
the participant to register using an email address as the
username. The app could also be downloaded to the carers’
phone in case the patient did not have a smartphone.
During the follow-up, the MyPathway app was used by study
participants for bidirectional interaction with the research team.
It consisted of positive feedback or reinforcement messages in
response to the number of hours of NIV use reported by the
patient daily. Also, general advice on specific NIV clinical
problems was automatically provided by the app according to
the patients’ weekly input. Additional educational material on
physical activity, diet, and sleep hygiene could be accessed at
any time via a dedicated link. A web-based clinical portal
enabled the research team to monitor the patient-reported NIV
hours of use and clinical problems. As indicated, a dedicated
nurse with clinical and technical knowledge (one of the authors,
MM) took the role of case manager to support collaborative
work. She used the web-based portal to identify adherence
problems and contacted participants via telephone or at home
(for those with severe mobility problems) to enquire about and
solve potential clinical or technical problems.
Procedures and Study Outcomes
The primary outcome was a change in self-efficacy, as measured
using the Self Efficacy in Sleep Apnea (SEMSA) questionnaire.
The SEMSA is a US-designed self-report questionnaire
comprised of 26 items that are rated from 1 to 4 on a 4-point
Likert scale [30]. The arithmetic mean of the Likert rating for
each participant is computed for the overall SEMSA score and
each of the 3 factors. The total score ranges from 1 to 4. Higher
scores indicate greater risk perception, higher benefit expectancy
with treatment, and greater perceived self-efficacy [30].
Secondary outcomes included usability of the ICT tool, as
measured using the System Usability Scale [31]; patient
satisfaction, as measured using the Net Promoter Score [32] in
addition to 3 custom general satisfaction questions measured
on a Likert scale; continuity of care, as measured using the
Nijmegen Continuity Questionnaire [33]; and the
Person-Centred Coordinated Care Experience Questionnaire as
described by Leijten et al [34]. Moreover, ventilator-specific
data such as the mean hours of daily use, unintentional leaks
(L/s), minute ventilation (L/min), tidal volume (mL), and backup
rate (breaths/min) were downloaded directly from the NIV
machine.
Tertiary outcomes included mortality; health-related quality of
life, as measured using the EuroQol 5D questionnaire [35,36];
and sleepiness, as measured using the Epworth Sleepiness Score.
The impact of the motivational mHealth tool recommendations
on diet and exercise was indirectly measured by body weight
changes.
All assessments were completed at baseline and the final visit
scheduled 3 months later. The follow-up was conducted in the
outpatient clinic for the control group and remotely by the nurse
case manager (MM) using the MyPathway app and its clinical
portal for the intervention group. When deemed necessary, the
nurse case manager visited the patient at home, or a visit was
scheduled in the outpatient clinics. There was no active
follow-up for the control group.
Randomization and Masking
All eligible patients were contacted by telephone to briefly
explain the study and invite them to participate. Those showing
interest were invited to the hospital outpatient clinics. Study
investigators (EB, EA, and MM) explained the study
face-to-face, and, in case of acceptance, signed consent was
obtained. Afterward, the patient was randomized. Before patient
enrollment, the randomization scheme was generated using the
website randomization.com by one of the researchers (EB).
Blocks of 4 were used. Only after the participant provided
consent, the investigator opened the envelope with the allocated
study group.
Due to the nature of the intervention, neither the participants
nor the investigators in direct contact with the participants were
blinded. Only the investigator in charge of data analysis was
blinded.
Sample Size Calculation, Data Management, and
Statistical Analysis
Accepting an α risk of 0.05 and a β risk of 0.2 in a two-sided
test, 31 subjects in the intervention group and 31 subjects in the
control group were required to achieve a statistically significant
difference ≥0.35 units in the SEMSA overall score [37]. The
common SD was assumed to be 0.46 [38]. A 10% drop-rate
was anticipated.
Baseline and end-of-study data (questionnaires) were collected
face-to-face at the outpatient clinic by the investigators (EB,
EA, and MM). Study data were collected and managed using
the REDCap electronic case report form [39,40] hosted at the
Hospital Clínic de Barcelona. Data on patient-reported NIV use
and clinical problems with NIV were collected online using
MyPathway.
Results are presented as mean (SD) or n (%). Comparisons were
conducted using Chi-square or Fisher exact tests for categorical
variables and Student t or Wilcoxon tests, depending on the
distribution of the variables, for numerical variables.
Ethics
Study approval was obtained from the Ethics Committee for
Clinical Research of Hospital Clínic de Barcelona
(HCB/2019/0510). Patients read, understood, and accepted
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Between February and March 2019, all patients already being
treated with NIV at the noninvasive ventilation clinic at the
Hospital Clínic de Barcelona were assessed for eligibility. From
an initial sample of 169 eligible patients, 50 (30%) did not meet
the inclusion criteria, including 32 who did not have a
smartphone or tablet, and 23 (14%) declined participation.
Therefore, 67 patients were randomized between February and
May 2019 (see the CONSORT flow diagram in Multimedia
Appendix 2). One patient from the intervention group withdrew
consent during the trial due to the worsening of his clinical
condition. Baseline demographic and clinical characteristics are
shown in Table 1 and Multimedia Appendix 3.
Patient-Reported Outcomes
For the primary outcome, the mean SEMSA score for
self-efficacy was not significantly different in the intervention
group after the intervention (before: 3.4, SD 0.6; after: 3.4, SD
0.5, P=.51).
The perceived risks, outcome expectancies, Epworth Sleepiness
Score, and EuroQol 5Q-5D questionnaire score were also not
significantly different in the intervention group after the
intervention (see Multimedia Appendix 3). As for the patient
experience questionnaires, neither the Nijmegen Continuity
Questionnaire nor the Person-Centred Coordinated Care
Experience Questionnaire were statistically significantly
different between the groups (see Multimedia Appendix 3).
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Table 1. Baseline characteristics of the study groups
P valueControl (n=34)Intervention (n=33)
.3165 (14.7)68 (15.8)Age (years), mean (SD)
>.9919 (58)19 (58)Male gender, n (%)
.1578 (22.4)86 (31.6)Weight, mean (SD)
.73Educational level (n, %)
1 (3)3 (9)No schooling
13 (38)12 (36)School education
19 (56)17 (52)Professional formation
1 (3)1 (3)Doctorate or equivalent
.3528.9 (7.4)30.5 (7.1)BMI (kg/m2), mean (SD)




.00352.5 (33)55.5 (35.7)Smoking (packs/year), mean (SD)
Diagnostic group, n (%)
.258 (24)4 (12)Neuromuscular
.8110 (30)11 (33)Chest wall
>.995 15)5 (15)Obesity-hypoventilation
.662 (6)3 (9)Airway obstructive disease
.608 (24)10 (30)OSAa to CSAb









.3203Neurological disorders other than stroke
>.991818Depression/anxiety
.542715Dyslipidemia
.084.5 (3.5)6.75 (6.5)Time on noninvasive ventilation (years), mean (SD)
.3735 (31.6)46 (28.8)AHIc, mean (SD)
.9144 (40.4)47 (37.3)CT90d (%), mean (SD)
Mean ventilatory parameters, mean (SD)
.0614 (4.7)16 (4.7)IPAPe (cm H2O)
.316 (2.1)7 (2.8)EPAPf (cm H2O)
.030.5 (0.09)0.05 (0.2)Leak (L/s)
.286.8 (3)7.4 (2)Number of hours used per day
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aOSA: obstructive sleep apnea.
bCSA: central sleep apnea.
cAHI: global apnea-hypopnea index for all diagnostic groups.
dCT90: cumulative sleep time percentage with oxyhemoglobin saturation <90%.
eIPAP: inspiratory positive airway pressure.
fEPAP: expiratory positive airway pressure.
Clinical Outcomes
Adherence was measured as the number of hours the NIV was
used per day, as recorded by the ventilator. The mean adherence
value was not significantly different in the intervention group
after the intervention (before: 7.4 hours, SD 2 hours; after: 7.7
hours, SD 2 hours). Mean minute ventilation was the only
significantly different ventilatory parameter after the 3-month
intervention in the intervention group (before: 7.0 L/min, SD 2
L/min; after: 6.4 L/min, SD 2.1 L/min, P=.03). The remaining
ventilatory parameters and weight are shown in Multimedia
Appendix 3. None of the patients died during the trial.
mHealth Tool Use, Usability, and Acceptability
The Net Promoter Score was –3 (10/33, 31% promoters; 11/33,
34% passives; 11/33, 34% detractors). The 3 Likert-scale
questions about the general satisfaction with the app that were
rated from 1 (very bad) to 10 (very good) resulted in a mean
score of 7.5/10 for the general impression of the app, mean score
of 8.2/10 for the user friendliness, and mean score of 8.5/10 for
usability of the app without assistance. The mean System
Usability Scale score was 78, a reasonably good grading. Up
to 42% of the participants used the link to the educational
material, and only 18% (6/33) consulted the terms of use. The
mean number of hours of NIV use per day, reported using the
mHealth tool, was 7.23 hours (SD 2.48 hours). Use of NIV for
more than 4 hours per day during two-thirds of the study period
was reported by 45% (15/33) of the patients. Likewise, the
reported mean number of days during which NIV was used
more than 4 hours in the entire intervention group was 35.6
days (SD 23.6 days). At the end of the study period, 3
participants stopped reporting due to app problems, 1 participant
stopped using the app due to health problems, another participant
stopped using the app for unknown reasons, and 3 participants
decided to use the app on an alternative day basis.
Also, 30% (10/33) of the participants used the app through a
family member or carer. It is of note that the nurse case manager
was able to solve two-thirds of the technical problems that arose
during the first 3 weeks of the study.
The qualitative analysis of the motivational interview as well
as the detailed description of the requirements for mHealth to
support collaborative work among stakeholders will be reported
elsewhere. However, Table 2 summarizes a list of features that
the research team agreed were key functional requirements of
mHealth tools to effectively support collaborative work among
stakeholders involved in home-based respiratory therapies.
Table 2. Requirements to support collaborative work within the noninvasive ventilation service.
Description of the requirement(s)Feature
Capacity to enable the case manager to combine predesigned tasks and approach new cases by
reusing structured experiences with previous cases. Over time, the case manager, or other autho-
rized health professionals, should be able to adapt the work plan in a timely fashion to specific
patient’s requirements without any direct technological support
Adaptive case management
Cloud-based, General Data Protection Regulation-compliant, enterprise-proven team collaboration
tools to allow patients and health care professionals to break down silos and collaborate seam-
lessly from any device (mobile phone, tablet, or desktop) towards the health continuum care
pathway
Team collaboration
Enterprise-grade, scalable, high-quality, real-time communication among concurrent participants
for file sharing, voice, video, and screen-share sessions with industry-standard encryption
Multimedia communication
Capacity to develop and integrate intelligent bots to guide professionals through continuum care
pathways and to improve health risk assessment and service selection
Intelligent bots
Use of HL7 Fast Healthcare Interoperability Resource interoperable middleware to integrate with
provider-specific hospital information systems
Integration with hospital information systems
Discussion
Principal Findings for Patient-Reported Outcomes
We report the results of a behavioral mHealth intervention based
on a face-to-face interview and the use of an mHealth tool
(MyPathway app) during a 3-month follow-up period with
patients with hypercapnic chronic respiratory failure under
home-based long-term NIV. To the best of our knowledge, this
is the first randomized controlled trial using digital tools to
support behavioral changes in this population [41-44].
In this study, the mean self-efficacy score was already high at
baseline (Table 1), and we did not find a significant effect of
the intervention on behavioral changes. Several explanations
can be proposed for these results. First, the intervention may
need to be more intensive (ie, more than one face-to-face
session) [45]. Second, all the participating patients were
long-term users without significant sleep symptoms at the time
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of enrollment (average use >6 years with an average Epworth
Sleepiness Score <10). Therefore, we could hypothesize that
behavioral changes had occurred previously, as evidenced by
the good average use of NIV (7.4 h/day) and high scores for
self-efficacy at baseline. The inclusion of patients who have
been newly prescribed NIV in future studies may show a
positive impact of the intervention. Third, we may argue that,
although NIV use was good among this sample of long-term
users, adherence was more a function of necessity or imposition
(by family or physicians) than a real feeling of self-management
and that most of these chronic patients had not considered
initiating behavioral changes [46,47]. Along this line of thought,
the population we studied had mobility problems or poor general
health, creating barriers for behavioral change [20]. Therefore,
any intervention at this stage is likely to be ineffective. This
may also be reflected by the lack of interest in consulting the
educational material in the app (<50% of the patients did so).
Last, we should note that the control group consisted of more
patients with neuromuscular pathophysiology. However, the
pathophysiology should not affect or have a direct relationship
with the measured behavioral outcomes or the capacity and
readiness to use the app. Accordingly, educational level is a
more important factor [48,49], and both study groups had similar
educational levels.
Usability, Acceptability, and Requirements for
Supporting Collaborative Work
Notwithstanding the clinical results, it is important to note that
the mHealth tool was well received by the patients and their
family/caregivers. Despite their complex conditions (2
comorbidities on average) with considerable needs and
burdensome treatment, all patients used the app regularly,
grading it as generally good, user-friendly, and easy to use
without help. Moreover, the System Usability Scale score was
good.
As stated in the methods section, we want to highlight the fact
that one of the authors (MM) undertook a new professional role
during the study period. She became the clinical case manager
with additional technical knowledge on the mHealth tool.
Patients appreciated this new role very much despite the use of
telephone or Whatsapp for bilateral communication. We found
that the app lacked this function, and based on our experience,
this should become an integral part of any app that includes
case management with technical skills. This type of
communication functionality should be cloud-based and General
Data Protection Regulation-compliant. Moreover, future
developments should consider adaptive case management
functionality. Also, this communication should be supported
by artificial intelligence to help guide professionals though
continuum care pathways and improve health risk assessment
and service selection. Finally, integration with hospital
information systems may facilitate the whole process. This is
in line with a recent report on the digital transformation of health
care in Europe, which draws upon the experiences of 17
integrated care programs where the importance of
communication technologies, new professional roles, and the
relevance of clinical workflow evaluation were highlighted [50].
In this respect, we measured 2 process outcomes [51] related
to patient experience [52]: continuity of care and
person-centered care. Our study population, which included
patients as well as their family and carers for one-third of the
cases in the intervention group, evaluated both parameters very
well. The importance of well-designed clinical workflows with
embedded digital health tools may have an impact on not only
an NIV service but also other respiratory services.
Commonalities include high-complexity patients with clinical
and social needs from different stakeholders (eg, physicians,
providers, technicians, social workers) and health care tiers (eg,
primary care, specialized care). Hernandez et al [24] showed
how this complexity can hamper the effectiveness of long-term
oxygen therapy. As mentioned, Table 2 shows the proposed
elements to overcome the barriers for the successful
implementation of digital health tools within clinical workflows
relating to respiratory therapies.
Finally, stakeholders play an important role in the design and
evaluation of digital health tools [53,54] and, as such, their input
should be taken into account when evaluating a service in which
there is considerable interplay between patients, different health
care tiers, and social and technical services [55]. For an mHealth
tool to produce health care value, it should be embedded in the
clinical pathways of a well-evaluated clinical service and not
as a standalone tool [56].
Strengths and Limitations of the Study
Our study considered the whole population of patients attending
the clinic, resulting in a realistic clinical scenario. Another
important strength of our study is its potential to demonstrate
the positive interaction and collaborative work among the nurse
case manager, patients, and family members or caregivers of
complex patients using digital health tools. Previous studies
[57-59] reported the use of digital tools by family caregivers,
emphasizing the importance of including this group of
stakeholders, not only as users but also in the co-design process.
This stakeholder involvement is also a further step in scaling
up digital health tools within clinical workflows [59], which,
in our case, were evaluated well. An interesting aspect of our
study was the collateral use of qualitative data collected from
the motivational interviews and by the nurse case manager
during follow-up. The qualitative results presented in Table 2
can be used to support the implementation of mHealth tools in
different contexts, keeping in mind the inherent limitations of
qualitative research data. We do acknowledge that, by using an
existing app, the co-design phase was skipped. Also, we did not
measure the technological literacy of our older population
(average age 69 years), but, according to Martinez-Alcala et al
[60], adults older than 60 years, if highly motivated, are capable
of learning and acquiring digital literacy skills. Nonetheless,
for some of our older patients (24% were 70-79 years old),
especially those with physical limitations (eg, visual
impairment), the motivation to learn and exploit all the app
functionality was low, although the perceived usefulness was
high. This agrees with other reports on the use of technology
by older adults [61,62]. Another potential limitation was the
heterogeneity of the study population, which directly influenced
the mean number of hours of use of the NIV machines and
precludes any interpretation. Nonetheless, we observe a strength
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in terms of the generalizability of the mHealth tools within the
heterogeneous population. Finally, a clear limitation of our
study was the exclusion of new NIV patients, where the
behavioral intervention may have had more impact. This
warrants further study.
Conclusions
The behavioral mHealth intervention explored in this study did
not show any effect on self-efficacy, adherence with NIV, or
quality of life in our population of experienced NIV users.
Nonetheless, we showed the potential of the mHealth app to
manage complex patients and foster collaborative work among
stakeholders. Regarding a clinical service that was graded well
in terms of continuity of care and person-centered care, in which
the needs of relevant stakeholders are properly addressed, we
see the potential to further study mHealth tools to induce
behavioral change in home-based ventilated patients as well as
in other respiratory therapies.
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